inquiry@healthyinc.co.in Export: +91-7400209539 +91-9833110409
Pioglitazone Tablets

Pioglitazone Tablets

Category: Therapy > Anti Diabetic Tablets
Product Name Pioglitazone Tablets

Short Description

Pioglitazone Tablets IP 15 mg

Each Uncoated tablet contains :

Pioglitazone Hydrochloride IP

Eq. To Pioglitazone 15 mg

Pioglitazone Tablets IP 30 mg

Each Uncoated tablet contains :

Pioglitazone Hydrochloride IP

Eq. To Pioglitazone 30 mg

Pioglitazone With Metformin Tablet

Each Film Coated Tablet contains :

Pioglitazone Hydrochloride IP

Eq. to Pioglitazone 15 mg

Metformin Hydrochloride IP 500 mg

Usage- Type 2 diabetes mellitus
Category- Anti Diabetic drugs
Therapeutic category- Anti Diabetic

Full Description

Pioglitazone Tablets Healthy Inc is a specialized global supplier and exporter of insulin sensitizers (Thiazolidinediones). We provide high-purity Pioglitazone Tablets, sourced from WHO–GMP certified solid dosage facilities. This "Insulin Resistance Breaker" is a top export to diabetology centers, metabolic clinics, and government health formularies in Africa, LATAM, and Southeast Asia, serving as a critical second-line or add-on therapy for Type 2 Diabetes patients who are resistant to insulin.

Product Overview

This formulation contains Pioglitazone Hydrochloride, a potent agonist of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ). The "Root Cause" Specialist:
  • Mechanism: Pioglitazone targets the root cause of Type 2 Diabetes: Insulin Resistance. It binds to the PPAR-γ nuclear receptors found chiefly in adipose tissue (fat cells), muscle, and liver.
  • Gene Transcription: This binding activates specific genes involved in glucose and lipid metabolism. It makes the body's cells more sensitive to its own insulin, allowing glucose to enter the cells more easily.
  • Lipid Benefits: Unlike other diabetes drugs, Pioglitazone significantly lowers triglycerides and increases HDL (Good Cholesterol), providing a dual metabolic benefit.

Product Composition & Strength

We supply this product as Uncoated Tablets (White/Off-White). The 15 mg and 30 mg strengths are standard for titration.
Active Ingredient Strength (Standard) Therapeutic Role
Pioglitazone HCl IP/BP/USP 15 mg Initiation Dose
Pioglitazone HCl IP/BP/USP 30 mg Standard Maintenance
Pioglitazone HCl IP/BP/USP 45 mg Maximum Daily Dose
Excipients Q.S. Lactose Monohydrate / Magnesium Stearate Filler / Lubricant
*Pack Sizes: Blister packs of 10s (Box of 10x10), 14s, 28s, or Bulk HDPE Jars of 1000s.

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers and Distributors.
HS Code 3004.90.99 (Other Medicaments)
Dosage Form Tablet (Uncoated)
Packaging Alu-Alu Blister or PVC-Alu
Storage Store below 25°C. Protect from moisture.
Certificates WHO-GMP, COPP, Free Sale Certificate

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
  • Polymorph Stability: Pioglitazone HCl exists in different polymorphic forms. We utilize the most stable crystal form to ensuring consistent dissolution and bioavailability over the shelf life.
  • Content Uniformity: The drug is active at milligram levels. High-shear mixing ensures that every 15 mg tablet contains exactly the labeled amount, preventing hypoglycemic variance.

Therapeutic Indications (Human Use)

Indicated for the management of Type 2 Diabetes Mellitus:
  • Monotherapy: For patients inadequately controlled by diet and exercise, particularly those who cannot tolerate Metformin.
  • Combination Therapy: Highly effective when added to Metformin (for insulin resistance) or Sulfonylureas (for insulin secretion) to achieve glycemic control.
  • NASH (Off-Label): Sometimes used for Non-Alcoholic Steatohepatitis (Fatty Liver) due to its liver fat-reducing properties.

Dosage & Administration

Recommended Dosage (Strictly as per Endocrinologist):
  • Route: Oral.
  • Adults: Initial dose 15 mg or 30 mg once daily.
  • Titration: Dose can be increased to 45 mg once daily if response is inadequate after 3-4 months.
  • Administration: Can be taken with or without food.
Safety Warnings:
  • Heart Failure (BLACK BOX WARNING): Can cause fluid retention, which may exacerbate or lead to heart failure. Do not use in patients with NYHA Class III or IV heart failure.
  • Bladder Cancer: Long-term use (>1 year) has a slightly increased risk of bladder cancer. Do not use in patients with active bladder cancer or history of it.
  • Bone Fractures: Increased risk of bone fractures in women.
  • Edema: Watch for rapid weight gain or swelling of the feet.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for OSD (Oral Solid Dosage) forms, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for government procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.

Related Products